Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5 studies found for:    ald403
Show Display Options
Rank Status Study
1 Completed Safety, Efficacy and Pharmacokinetics of ALD403
Condition: Migraine
Interventions: Biological: ALD403;   Drug: Placebo
2 Completed Safety Tolerability and Pharmacokinetics of ALD403
Condition: Migraine Disorders
Interventions: Biological: ALD403;   Biological: Sumatriptan
3 Active, not recruiting A Multicenter Assessment of ALD403 in Chronic Migraine
Condition: Migraine Disorders
Interventions: Biological: ALD403;   Biological: Placebo
4 Not yet recruiting Evaluation of ALD403 in the Prevention of Chronic Migraine
Condition: Migraine Disorders
Interventions: Biological: ALD403;   Biological: Placebo
5 Active, not recruiting A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
Condition: Migraine Disorders
Interventions: Drug: ALD403;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.